ERN1 and neoplasm: Our findings demonstrate that targeting IRE1 arm of the UPR pathway reduced tumor progression and prevented cardiac dysfunction associated with chemotherapy treatment in control and Western diet‐fed mice with TNBC tumors, representing a novel combinatorial neoadjuvant therapy regimen to protect the heart while sensitizing the tumor concurrently.